216 related articles for article (PubMed ID: 26092157)
1. Bioenergetics of the spinal cord in experimental autoimmune encephalitis of rats.
Al-Shamsi M; Shahin A; Ibrahim MF; Tareq S; Souid AK; Mensah-Brown EP
BMC Neurosci; 2015 Jun; 16():37. PubMed ID: 26092157
[TBL] [Abstract][Full Text] [Related]
2. Brain inflammation in experimental autoimmune encephalomyelitis induced in Dark Agouti rats with spinal cord homogenate.
Stegnjaić G; Jevtić B; Lazarević M; Ignjatović Đ; Tomić M; Nikolovski N; Bjelobaba I; Momčilović M; Dimitrijević M; Miljković Đ; Stanisavljević S
Immunol Lett; 2024 Jun; 267():106852. PubMed ID: 38508497
[TBL] [Abstract][Full Text] [Related]
3. Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant.
Lorentzen JC; Issazadeh S; Storch M; Mustafa MI; Lassman H; Linington C; Klareskog L; Olsson T
J Neuroimmunol; 1995 Dec; 63(2):193-205. PubMed ID: 8550817
[TBL] [Abstract][Full Text] [Related]
4. Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system.
Matsumoto Y; Ohmori K; Fujiwara M
J Neuroimmunol; 1992 Mar; 37(1-2):23-33. PubMed ID: 1372328
[TBL] [Abstract][Full Text] [Related]
5. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: modulation by oral administration of myelin basic protein.
Popovich PG; Yu JY; Whitacre CC
J Neuropathol Exp Neurol; 1997 Dec; 56(12):1323-38. PubMed ID: 9413281
[TBL] [Abstract][Full Text] [Related]
6. Correlation of nitric oxide levels in the cerebellum and spinal cord of experimental autoimmune encephalomyelitis rats with clinical symptoms.
Ljubisavljevic S; Stojanovic I; Pavlovic D; Milojkovic M; Vojinovic S; Sokolovic D; Stevanovic I
Acta Neurobiol Exp (Wars); 2012; 72(1):33-9. PubMed ID: 22508082
[TBL] [Abstract][Full Text] [Related]
7. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-beta.
Issazadeh S; Lorentzen JC; Mustafa MI; Höjeberg B; Müssener A; Olsson T
J Neuroimmunol; 1996 Sep; 69(1-2):103-15. PubMed ID: 8823381
[TBL] [Abstract][Full Text] [Related]
8. Induction of experimental autoimmune encephalomyelitis in Dark Agouti rats without adjuvant.
Stosic-Grujicic S; Ramic Z; Bumbasirevic V; Harhaji L; Mostarica-Stojkovic M
Clin Exp Immunol; 2004 Apr; 136(1):49-55. PubMed ID: 15030513
[TBL] [Abstract][Full Text] [Related]
9. Cytokine and chemokine alterations in tissue, CSF, and plasma in early presymptomatic phase of experimental allergic encephalomyelitis (EAE), in a rat model of multiple sclerosis.
Borjini N; Fernández M; Giardino L; Calzà L
J Neuroinflammation; 2016 Nov; 13(1):291. PubMed ID: 27846891
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of Bcl-2 in the spinal cords of rats with experimental autoimmune encephalomyelitis.
Moon CJ; Lee YD; Shin TK
J Vet Sci; 2002 Dec; 3(4):279-83. PubMed ID: 12819378
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology.
Matsumoto Y; Hara N; Tanaka R; Fujiwara M
J Immunol; 1986 May; 136(10):3668-76. PubMed ID: 3084638
[TBL] [Abstract][Full Text] [Related]
12. Lack of apoptosis of infiltrating cells as the mechanism of high susceptibility to EAE in DA rats.
Lukic ML; Mensah-Brown E; Galadari S; Shahin A
Dev Immunol; 2001; 8(3-4):193-200. PubMed ID: 11785669
[TBL] [Abstract][Full Text] [Related]
13. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum stress response in immune cells contributes to experimental autoimmune encephalomyelitis pathogenesis in rats.
Vidicevic S; Tasic J; Stanojevic Z; Ciric D; Martinovic T; Paunovic V; Petricevic S; Tomonjic N; Isakovic A; Trajkovic V
Immunol Lett; 2024 Jun; 267():106855. PubMed ID: 38537720
[TBL] [Abstract][Full Text] [Related]
15. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
16. [3H]thymidine labeling of astrocytes in experimental allergic encephalomyelitis.
Smith ME; Gibbs MA; Forno LS; Eng LF
J Neuroimmunol; 1987; 15(3):309-21. PubMed ID: 3298318
[TBL] [Abstract][Full Text] [Related]
17. Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis.
Liu X; Yao DL; Bondy CA; Brenner M; Hudson LD; Zhou J; Webster HD
Mol Cell Neurosci; 1994 Oct; 5(5):418-30. PubMed ID: 7529631
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of inflammation, cytokine mRNA expression and disease course of relapsing experimental autoimmune encephalomyelitis in DA rats.
Lorentzen JC; Andersson M; Issazadeh S; Dahlman I; Luthman H; Weissert R; Olsson T
J Neuroimmunol; 1997 Dec; 80(1-2):31-7. PubMed ID: 9413257
[TBL] [Abstract][Full Text] [Related]
19. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
20. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
Milicevic I; Pekovic S; Subasic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Medic-Mijacevic L; Pejanovic V; Rakic L; Stojiljkovic M
J Neurosci Res; 2003 Apr; 72(2):268-78. PubMed ID: 12672002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
